Commissioned researchWhich peptides are people actually buying and injecting outside clinical settings, and what do they report?
BPC-157 + TB-500 is the anchor of a $1–3bn gray market that a July 2026 FDA advisory vote has just cracked open toward legal compounding — the winnable position for a wellness brand is verified sourcing and batch-specific third-party COAs, not efficacy claims.
Executive summary↑
The peptide conversation is dominated by a small, stable set of compounds: BPC-157 appears in 94 items (18.3% share of voice, 526k engagement), FDA in 43, TB-500 in 41, KPV in 22 and CJC-1295 in 19 — with BPC-157 + TB-500 repeatedly named as "the most-used soft-tissue repair pair" 1,2,34,5,6. Volume is event-driven, not organic: weekly item counts jump from 14 (W26) to 185 (W30), coinciding with the FDA Pharmacy Compounding Advisory Committee meeting of 23–24 July 2026, which voted (8-6-1, then four straight YES votes) to recommend BPC-157, TB-500, KPV and MOTS-c for the 503A compounding bulk list against FDA staff's own recommendation not to add any of them 7,8,910,11,1213,14,15. That vote is a recommendation, not approval, and reporting on it is genuinely contradictory — some sources report rejection of all seven, others report loosened access 16,17,1819,20.
What buyers report is bifurcated. Claimed results are dramatic and testimonial (pain resolution, 25lb loss, restored hair pigment, discontinued prescriptions) 321, but the same threads carry blunt self-awareness — "we're all injecting questionable compound with little evidence in humans other than anecdotes" — and frequent nil-effect reports 3222324. The regrets are overwhelmingly about sourcing, not pharmacology: a $13,000 vendor exit scam, $600 and $800 losses, fake shipping companies, and endemic COA fraud where resellers reuse old certificates and order matching cap colours 252627,28. Independent testing referenced by Dr Eric Topol puts mislabelling at roughly 20%, and one documentary-tested ipamorelin vial contained 0% ipamorelin plus arsenic and lead 29.
Stance is close to evenly divided (pro 103, anti 103, mixed 57, na 119 items), but pro content carries far more engagement (375k vs 56k) — the gray market wins on reach, the critics on volume of caution. Clinician alarm is consistent and cross-source: no long-term human safety data, zero human RCTs for BPC-157, no human studies at all found for TB-500 30,31,3233,34,3513. In China, Xiaohongshu is the single largest community in this corpus (84 items) but functions mainly as a B2B export marketplace for lyophilized peptide powder with dedicated customs-clearance shipping lines to the US/UK/EU — this is the upstream supply chain, not the consumer 36,37,38.
Inference, clearly labelled: the commercially defensible entry is not a peptide efficacy claim. It is the trust layer — verified identity, pharma-grade or FDA-registered sourcing, and public batch-level third-party COAs — because that is the explicit, quantified, unmet complaint in the buyer communities, and because incumbents (Hims & Hers, Empower, Olympia) are already building the compounding channel 39,40,9.
Volume over the window↑
Items per ISO week across the 30-day window. 59 items carried no parseable date and are excluded.
Findings↑
What people are actually buying: a short, concentrated list led by BPC-157 + TB-500high confidence
The metrics are unambiguous about concentration. BPC-157 is mentioned in 94 distinct items (18.3% share of voice, 526,284 engagement, present on ten platforms including Reddit, X, TikTok, YouTube, WeChat, Xiaohongshu and Zhihu). TB-500 follows at 41 items (8.0%), KPV at 22 (4.3%), CJC-1295 at 19 (3.7%), Ipamorelin at 10 plus 7 lowercase variants, GHK-Cu at 9, Retatrutide at 9. GLP-1 terms fragment across English and Chinese spellings (semaglutide 9, tirzepatide 9+8, 替尔泊肽 13, GLP-1 12).
Qualitative evidence matches: a Rite Aid page lists "BPC-157 + TB-500 — the most-used soft-tissue repair pair" and "CJC-1295 + Ipamorelin — the standard GHRH + GHRP pair for recovery and sleep" 1,2,33,41,1. Users report BPC-157 twice daily for workout recovery and gut repair 1,2,3, and a YouTube creator ran a two-month BPC-157/TB-500 cycle for a torn hip labrum in place of surgery 4,5,6.
Buying happens in stacks, not single SKUs. Self-experimenters describe capping at "3-4 peps at a time" — e.g. tirzepatide + tesamorelin/ipamorelin + GHK-Cu + an energy compound (NAD, MOTS-c or L-carnitine) 3,41,1. Branded blends circulate as fixed products: "GLOW" (GHK-Cu + BPC-157 + TB-500/TB-4) and "KLOW", dosed by unit-conversion math in tracker apps 2342,43,44. Heavier users combine TRT, retatrutide, GH secretagogues and mitochondrial peptides (SS-31, MOTS-c) in one protocol, with retatrutide split 6mg across Monday/Friday 45.
Sub-categories with their own named rosters exist but are smaller: cognitive (Semax, Selank, Pinelon, Dihexa) 46, post-addiction dopamine recovery (Semax, Selank, 9-me-BC, Bromantane) 47, nerve repair (ARA-290, framed as distinct from BPC/TB-500) 48,49, and unsupervised HGH at 2–7 IU/day 50.
Inference: basket composition, not single-product demand, is the design unit. Any entrant offering one compound is competing against a stack habit.
The regulatory window: a 23–24 July 2026 advisory vote that is being over-read as approvalhigh confidence
Volume in this corpus is regulatory-event-driven. Weekly item counts run 14 → 32 → 36 → 56 → 185 across 2026-W26 to W30, and "FDA" is the second-largest entity at 43 items (8.4%, 195k engagement) — larger than TB-500. This spike maps onto the FDA Pharmacy Compounding Advisory Committee (PCAC) meeting held 23–24 July 2026 51,52,5310,11,12.
What the committee did: it reviewed seven peptides (BPC-157, TB-500, KPV, MOTS-c on day one; DSIP, Semax/Selank, Epitalon on day two), voted 8-6-1 on day one and then delivered four YES votes to recommend BPC-157, TB-500, KPV and MOTS-c for the 503A bulk drugs compounding list — explicitly against FDA staff's own recommendation not to add any 7,8,910,11,1216,17,18. A separate 8-5 vote recommended Semax 51,52,53. CJC-1295 and Ipamorelin were declined in 2024 and remain restricted, and are not returning via this process 54,55. GHK-Cu is slated for a second meeting before February 2027 54,55.
What it did not do: approve anything. A urologist who testified explains the next step is a 30–60 day public comment period before rulemaking 10,11,12; a TikTok creator estimates 6–12 months to actual approval while simultaneously framing it as "a really big win" 56,57.
Reporting is contradictory and a sceptical reader should be told so. One YouTube physician reports FDA reviewers concluded all seven should be rejected 16,17,18; an X account states "the FDA rejected all 7 peptides... [yet] the PCAC recommended the addition of BPC157, KPV, TB500, and MotsC despite the fda saying hell nah" 19,20. Both accounts are reconcilable — FDA staff recommended against, the committee voted for — but the public narrative has collapsed the distinction. Chinese-language coverage independently reports the same 23 July panel recommending BPC-157 be unbanned 54,55, and WeChat coverage names the same four compounds 58,59,60.
Context: FDA moved 19 popular peptides to Category 2 ("do not compound") in 2023; HHS Secretary RFK Jr. has called that ban "illegal", signalled in February 2026 that restrictions were pushing patients to the gray market, and announced an April 2026 reclassification framework 13,14,1554,5556,57. Panelists with peptide-industry ties were reportedly added before the vote 13,14,1561,62,3263,64,65.
The sourcing gray market: $1–3bn, Chinese B2B upstream, 'research use only' as the legal fig leafhigh confidence
Bloomberg's Big Take puts the peptide black market at an investor-estimated $1–3 billion, operating through a specific mechanism: powdered APIs labelled "research use only, not for human consumption" are imported from China, then reconstituted with sterile water at home for injection 60,66. Commentators call the label "a fig leaf" 65,67; a Zhihu recap and WeChat coverage describe the same RUO framing in Chinese 68,69,70.
The upstream is visible and organised. Xiaohongshu is the largest single community in this corpus (84 items, 18,861 engagement) and functions overwhelmingly as B2B, not consumer: source factories (源头工厂) advertise 99%+ purity, COA/lab testing, customisable cartridge vials, and dedicated shipping lines — US 4–6 days, UK 3–7, Canada 3–9, Europe 7–13 — explicitly targeting skincare brands, e-commerce and cross-border traders 36,37,38. One seller post complains a shipment was held at customs despite being packaged as "ordinary cosmetic powder" 36,37,38. Others advertise export credentials and "no middleman" pricing 71,72,73.
Distribution into Western consumers runs through Telegram, Discord, TikTok and Instagram. TikTok accounts run "current research range" stock charts with #ResearchOnly hashtags (91,071 views) and solicit "wholesale" comments to onboard resellers with label, packaging and website services plus two-day domestic shipping 71,72,73. Chinese independent sales sites camouflage as e-cigarette-accessory, 3D-printing, maternity or clothing storefronts, with real transactions on a separate 特货 ("special goods") platform 74,75.
Pricing signals in the corpus: kits of 10 vials described as lasting a year for $200 76; $35 for 10 vials called "a guaranteed scam, no matter what's in it" 77; $50–90 shipping normalised, waived above $400–500 orders 78; one high-volume buyer ordering ~$3,500/week 79; another reporting orders of $7k per transaction 25.
A parallel Chinese regulatory-crackdown narrative exists: 14 people sentenced and fined for illegal production/sale of "weight-loss miracle drugs", with Chinese outlet Pengpai questioning whether injectable anti-aging peptides are proven safe 74,75.
The regrets are about fraud and purity, not pharmacology — this is the wedgehigh confidence
The most emotionally loaded content in this corpus is not about side effects. It is about being robbed.
Documented losses: a $13,000 exit scam where a successful $300 order built false trust 25; commenters reporting $800 and $1,800 losses in the same thread 25; $600 lost to "Zen Peptide Supply China" via a fake shipping entity "Swiftlane Maritime" 26; $400 80; $107 to a vendor called "PrimeRX" 81,82; a buyer who "bought from china and they never sent me anything" 78. Community self-policing tactics are elaborate: check the vendor against Janoshik's public COA database, join the vendor community for several days to detect fake activity (one reports "a scammer group of fake uther with 10k members"), never pay crypto, prefer PayPal/Alipay/Alibaba-only suppliers, insist on UPS/FedEx shipping, spread orders across vendors, and group-test batches to split costs 2526807983.
COA fraud is described as endemic. Resellers reuse previous batches' COAs while awaiting new ones, and order custom cap colours to match a COA found online from a different batch 27,28. A biohacking TikTok creator says she found 4–5 companies selling with expired or absent COAs, one seller admitting "we haven't gotten them back yet, but I use that one and it's fine", and argues "probably 90% of peptide companies out there are selling peptides that are not verified" 27,28 — note this 90% figure is one creator's estimate, not a measurement. Reddit's own summary: "Most COAs are fake. Buy, test and hope for the best," with basic testing ~$250 and complete testing ~$600 per kit 77. One buyer says lab testing is 75% of their peptide expense 78.
The hardest independent number in the corpus: cardiologist Dr Eric Topol states that when gray-market peptides are studied by independent labs, "20% or so aren't even what the peptides they say they were supposed to be" and often contain impurities; the same documentary sent an ipamorelin product for testing and got 0% ipamorelin detected, with arsenic and lead present instead 29. In PED communities, pharma-grade vs underground-lab sourcing is treated as the single variable explaining whether HGH works at all: "If it's UGL, could be weeks to months or possibly never if it's bunk" 50.
Buyers do not agree on the fix. Some argue paying more to a US reseller buys reduced sourcing risk; others insist "all peptides come from 2 factories. All is same" 80. Dissent exists that the scam narrative unfairly generalises: "plenty of amazing vendors to be had if take the time to vet them" 80. One vendor, ElliotMeds, is praised specifically because "they have a doctor prescribe it for you and it comes from a pharmacy so you know it's legit" — while another commenter counters "any way you slice it you're getting ripped off" 84.
Inference: verified identity + batch-specific, publicly posted third-party COAs + conventional payment with refund recourse is the exact bundle this market is manually and expensively reconstructing for itself. That is a product, not a marketing message.
What users report: dramatic testimonials, frequent nil results, and open acknowledgement that it's anecdotehigh confidence
Stance is almost perfectly split by item count — pro 103, anti 103, mixed 57, na 119 — but pro content carries 375,238 engagement against anti's 55,940. Enthusiasm travels; caution does not.
Claimed wins. A user reports pinning "13 times a day" with optimised blood markers and two prescription medications discontinued with doctor approval; another reports six years of physio-resistant stiffness resolving within a month of CJC-1295 + BPC-157, plus 25lb lost, running again, "NO MORE PAIN" 3. BPC-157 users report improved workout recovery and resolved food intolerances 1,2,3, and regained use of hip and shoulder after three surgeries in one year 1,2,3. GHK-Cu users report thicker hair, softer skin, lightened moles, faster nail growth, and under-eye circles "completely gone" after a lifetime 22; a 71-comment, 111-upvote thread centres on multiple independent users reporting gray hair re-pigmentation on GHK-Cu, sometimes only when stacked with tirzepatide 21.
Claimed nil results and adverse effects, often in the same thread. A seven-month GHK-Cu user: "i havent noticed ANYTHING" 22; "KLOW80 did absolutely nothing for me, to the point I have wondered if my entire kit was bunk" 23; "Im on week 3 of ghk-cu and have seen nothing yet. 3mg a day" 23; "Nad + did nothing for me" 24. Novel self-named side effects appear — "GHK fatigue" forced one user to stop 22. On energy peptides, one user who "tried them all" reports MOTS-c and NAD+ didn't work and SLU-PP-332/5-amino faded over 3–4 weeks, concluding testosterone "is the only thing that works day in and day out" 24. HGH self-dosers at 6 IU report numbness and carpal-tunnel symptoms 50. On the PED side, Clenbuterol is called "obsolete" and displaced by retatrutide/tirzepatide, with one user reporting chest pain after three months of 6mcg every other day 76.
Epistemic self-awareness is high and matters for messaging. In the same thread as the glowing testimonials: "But at least medications are scientifically proven. We're all injecting questionable compound with little evidence in humans other than anecdotes... It's a recipe for disaster and I know it" 3. On GHK-Cu: "Youre going to be waiting for a long time if you want to see legit before/after pics showing the wonders of ghk-cu lmao" 22. On mega-stacks: "Too much. You don't know what is working or not" and "Taking every peptide available makes zero sense" 85. In a cognition thread, the top-voted answer to "peptides to enhance memory" was simply "It's called sleep" 46.
Inference: this audience is not credulous. It is under-served. A brand that leads with hype will be dismissed by the same commenters who dismiss vendors; a brand that leads with verification and explicitly declines to promise outcomes is speaking their language.
Clinician alarm is consistent, cross-source, and specific enough to be quotable against youhigh confidence
The clinician position is not fragmented opinion — it converges. UCHealth warns people "to be very cautious and to wait for scientific evidence showing whether peptides are beneficial or harmful"; HonorHealth's Dr Dean notes online peptide products "aren't FDA approved... not regulated for safety or effectiveness"; the Washington Times frames them as "unproven substances... despite little evidence they are safe or effective" 30,31,32.
The evidence base as stated by FDA staff: five BPC-157 studies "were of short duration, had small sample sizes and evaluated doses that were likely exploratory in nature"; for TB-500, regulators could not find any human studies at all; and FDA associate director Russell Wesdyk noted "there's no way to know what the substance actually is, was or will be tomorrow because that name has no legal meaning" 13. Independent science communicators corroborate: "there are currently zero randomized control trials studying bpc 157 in humans", the sole human study being a retrospective, uncontrolled, 16-person knee-pain study 33,34,3586. USADA has banned BPC-157 in competition 86. FDA reviewers found the evidence "unanimous across the board... do not recommend to move forward", with three of the peptides showing "very troubling flags for potentially being linked to cancer" 87,88,89. Regulators also raised contamination, allergic reaction and quality control risks 16,17,18.
Physicians on r/medicine read the advisory vote as regulatory capture: "so we just swapped conflict of interest pharma folks with conflict of interest peptide charlatans?"; "I guess GI docs will do well scoping people for colon cancers after millions of people take pro-VEGF peptides"; and a physician who had patients at the New England Compounding Center one day before its tainted medications shipped writes that he "really worr[ies] that the floodgates are about to open on compounders again" 7. KFF's Amy Maximen warns the vote "will be mistaken as approval" 61,62,32. One clinician-adjacent X account claims ER visits are rising from people "injecting research chemicals they found on Reddit" — this is a single unquantified assertion and should not be repeated as fact 81,82.
The AMA's stated position is the one usable benchmark for a brand: unapproved synthetic peptide products should undergo FDA regulatory review and third-party testing to demonstrate safety and efficacy before marketing or clinical use 90.
There is a counter-current worth noting: clinicians do exist who prescribe supervised stacks — Dr Bal Nandra at Transform RX sources only from FDA-registered facilities 90, and an X-based clinician describes a patient improving over 90 days on BPC-157/CJC-1295/ipamorelin with nutrition and sleep changes 42,43,44.
GLP-1 as the gateway: how the audience got comfortable with needleshigh confidence
The single clearest behavioural mechanism in the corpus is that GLP-1 normalised self-injection. A therapist profiled by Bloomberg started Zepbound in May 2024, lost 200lb in two years, then began injecting GHK-Cu for post-loss skin sagging plus glutathione via a functional-medicine doctor's compounding pharmacy — her words: "I honestly think GLP-1s have just been a gateway drug to peptides" 60,66. A reporter describes Silicon Valley "peptide raves" where attendees comfortable with off-brand Ozempic moved to epitalon and MOTS-c: "if Ozempic is like a magic shot for weight loss, what if there was a magic shot for everything else, whether it's sleep or fitness or my skin" 60,66.
The stacking is now explicit: a Reddit user asks "Can I take KLOW while on wegovy?" 45, and Reddit commenters direct peptide buyers to GLP-1 forums as the only trustworthy vendor source: "Everyone just go to glp1 forums. All legit suppliers. End of story. Anything else is a scam" 26.
GLP-1 users are also intensely cost-sensitive and tool-hungry. In r/tirzepatidecompound, drawing residual units from an emptying vial and topping up from a new one across two syringes is standard practice, supported by community dose-transition calculators (glapp.io, fatscientist.com): "I use every drop I can get out of the old vial!" 91. Peptide schedulers are improvised from Apple Health medication reminders 45.
China shows the same behaviour with a harder edge. WeChat and Xiaohongshu carry week-by-week self-injection diaries: 7 jin lost in a month on tirzepatide 92,93,94; 1.8kg in 7 days with "side effects fiercer than I imagined" 95,96; a liraglutide diary running "from 130 jin to vomiting and IV drip" then plateauing near 63.6kg 95,96; a week-3 diary warning of "big side effects, easily damages stomach, easy binge rebound" and advocating low-dose gradual protocols over "aggressive drug for dropping weight fast" 92,93,94. A Xiaohongshu post: "Wake up — the cost of losing weight via injection is truly unbearable" 95,96. The corpus figures layer confirms the rebound theme: an 80% figure appears with "反弹包的，80%都会反弹" (80% will rebound), and a 25–40% figure recurs regarding the share of lost weight that is muscle. A WeChat nutritionist describes a consumer hospitalised in dehydration shock after self-injecting illegally-sourced semaglutide 97,98,99, and Zhihu users report 20kg lost in 5 months with 3kg regained within 3 months of stopping, and "stopping the drug basically always causes rebound" 97,98,99.
Inference: the highest-intent, most reachable audience for a trust-first peptide product is the post-GLP-1 population — already needle-comfortable, already cost-conscious, already looking for the "next" shot, and already worried about skin laxity and muscle loss. Discontinuation support and body-composition preservation are the adjacent needs the evidence actually voices.
The competitive field is already moving — and the gray market will not vacatehigh confidence
Legitimate incumbents are pre-positioned. Hims & Hers bought a peptide manufacturing facility in February 2025 and is developing clinical protocols per its CMO; Olympia Pharmaceuticals' president says the company has been "spending a lot of money to create these formulas" ahead of an anticipated green light; Forbes frames a "potential multi-billion-dollar market within reach" for Empower, Hims & Hers "and a slew of others" 39,40,9. Nu Image Medical publicly celebrated the vote day 39,40,9.
But informed commentators expect the gray market to persist. A physician-creator states plainly: "does that mean that the gray market is gone? Absolutely not... most of the things in the compounding pharmacy world are still going to be significantly higher than other means" 52,51. Another argues "the gray market isn't shrinking, it's exploding" because the medical system fails people with chronic pain, gut issues and injuries 52,51. Chinese coverage reaches the same conclusion: Reddit communities and "hundreds of protesters" show that "regulation won't stop consumer self-injection" 87,88,89.
Gray-market prices are the benchmark to beat or reframe: kits of ten vials for ~$200 lasting a year 76, versus $250–600 per kit for independent testing that buyers currently pay themselves 7778. Influencer discount codes of 5–30% off are standard in the gray channel (the figures layer shows recurring 10%, 15%, 20%, 25%, 30% and 50% discount mentions, with named vendors like Ascension Peptides at 50% off auto-ship and Ion Peptide at 15%).
The information channel is creator-led and there is an acknowledged vacuum. r/Peptides users name a specific roster of trusted physician-influencers (Dr Ashley Froese/Frazey, Alex Tatem/Tatum, Trevor Bachmeyer, Nick Trigili, Ryan Humiston) rather than official guidance, and one commenter states outright: "There definitely is a gap in the market for an awesome peptide channel to dominate" — while another criticises a creator for pushing a paid "blackcard" product 100. Regulatory status is being mis-explained on social: a TikTok creator correctly notes bulk-listing does not permit prescription compounding yet, but frames it as a win with a 6–12 month approval horizon 56,57.
Inference: the differentiation available to a wellness brand is not price and probably not speed to market against Hims & Hers. It is verifiability plus accurate regulatory communication — occupying the credibility gap that both the gray market and the hype creators leave open.
Implications↑
Do not launch an injectable BPC-157 or TB-500 product on the strength of the July 2026 PCAC vote. Treat the vote as a watch-item, not a green light, and set an internal gate at final FDA rulemaking.
highThe PCAC vote was a non-binding recommendation against FDA staff's own advice, requires a 30–60 day comment period plus rulemaking, and reporting on the outcome is contradictory — some sources report all seven peptides rejected, others report loosened access 7,8,910,11,1216,17,1819,20. FDA staff found no human studies at all for TB-500 and flagged three of the seven for possible cancer links 1387,88,89. Panel composition is under conflict-of-interest scrutiny including from KFF and physicians on r/medicine 61,62,327. If ignored: a launch built on a misread of 'approval' inherits the exact liability and reputational exposure that the AMA, the FDA staff review and the compounding-disaster precedent all point at 907.
Enter first with the trust layer, not the molecule: publish batch-specific, lot-tracked third-party COAs on a public URL for every SKU you sell, name the testing lab (Janoshik is the community's existing reference standard), and make heavy-metal screening explicit.
highCOA fraud is the single most-repeated complaint: resellers reuse prior-batch COAs and order matching cap colours to fake verification, and buyers conclude 'Most COAs are fake. Buy, test and hope for the best' 27,2877. Buyers already pay $250–600 per kit to self-test and organise group buys purely to split testing costs — one says testing is 75% of their peptide spend 777879. The quantified hook is Topol's ~20% mislabelling rate and the tested ipamorelin vial containing 0% ipamorelin plus arsenic and lead 29. If ignored: you are indistinguishable from the gray vendors this audience has been trained to assume are scamming them, and you forfeit the only claim you can make that is both true and verifiable.
Position on sourcing and identity verification, and explicitly avoid outcome claims. Say where it was made, who tested it, and what is in the vial — never that it heals tendons, regrows hair or reverses gray.
highThere are zero randomised human trials for BPC-157 (one 16-person retrospective study) and no human studies located for TB-500 33,34,358613. Self-reported results are wildly inconsistent — the same GHK-Cu threads contain 'dark circles completely gone' and 'i havent noticed ANYTHING' and 'KLOW80 did absolutely nothing' 2223. Crucially, the audience already knows this: 'We're all injecting questionable compound with little evidence in humans other than anecdotes' 3. Media narrative across UCHealth, HonorHealth, Guardian and Washington Times is uniformly 'not approved, not regulated' 30,31,32. If ignored: efficacy claims invite both regulatory action and community derision, and burn the credibility that is the whole asset.
Target the post-GLP-1 cohort as the beachhead audience — people who finished or are tapering a GLP-1 and are worried about skin laxity, muscle loss and rebound — and lead with cosmetic/topical GHK-Cu and non-injectable formats rather than injury-repair injectables.
mediumGLP-1 is documented as the gateway that normalised self-injection, with one profiled user moving to GHK-Cu specifically for post-weight-loss skin sagging 60,66. GHK-Cu has organic, named community buzz around skin, under-eye and hair claims and is a lower-regulatory-risk cosmetic entry than injury-recovery injectables 2221. Rebound and muscle-loss anxiety is loud, especially in China: 80% rebound claims, 25–40% of lost weight as muscle, 20kg lost then 3kg regained in 3 months 97,98,9992,93,94. Note GHK-Cu is not in the July 2026 tranche — it is slated for a second PCAC meeting before Feb 2027, so injectable GHK-Cu has no near-term legal compounding path 54,55. If ignored: you compete head-on with Hims & Hers and Empower in the injectable channel they have been building since February 2025 39,40,9.
Open a compounding-pharmacy partnership track now (503A relationship, FDA-registered facility sourcing, prescriber network) as a parallel option, and hold it until rulemaking — but price it against a ~$200-per-10-vial-kit gray benchmark and assume the gray market does not vacate.
mediumThe AMA's stated bar is FDA review plus third-party testing before marketing or clinical use, and the clinicians who do prescribe (e.g. Dr Bal Nandra) differentiate on FDA-registered facility sourcing 90. RFK Jr.'s explicit rationale for easing rules is shifting consumers off the unregulated online market 90. But commentators expect compounding prices to remain 'significantly higher than other means', so the gray market persists or grows 52,5187,88,89. Gray kits are cited at ~$200 for a year's supply 76. If ignored: you either arrive after the compounding incumbents have locked prescriber relationships, or you launch at a price the community openly ridicules.
Build the ancillary trust-and-tools layer as a low-risk first product: accurate regulatory-status explainers, dose-conversion and vial-transition calculators, and a vendor/COA verification resource — distributed via r/Peptides, r/Biohacking and a credentialed-clinician YouTube channel, not via TikTok #ResearchOnly ads.
mediumCommunity members explicitly state 'There definitely is a gap in the market for an awesome peptide channel to dominate' and currently rely on a handful of physician-influencers, one of whom they criticise for monetising a paid 'blackcard' 100. Regulatory status is being actively mis-explained on social — bulk-listing framed as near-approval 56,57 — and KFF warned the vote 'will be mistaken as approval' 61,62,32. GLP-1 users already improvise with third-party calculators (glapp.io, fatscientist.com) and Apple Health reminders, showing demand for tooling 9145. The Reddit communities are where vetting actually happens (r/Peptides 14 items/110 comments read, r/Business_China 9 items/139 comments read, r/Biohacking 5 items/58 comments read per the community map). If ignored: you cede the credibility channel to gray-market-adjacent creators and enter later with no earned standing.
Rule out any Chinese Xiaohongshu/Telegram 'source factory' supplier for own-label supply, and require verified corporate identity, conventional payment rails with refund terms, and named-carrier logistics in any supplier contract.
highXiaohongshu is the largest community in this corpus (84 items) and is functionally a B2B export marketplace advertising customs-clearance shipping lines, with at least one seller reporting a shipment held for shipping peptide powder as 'ordinary cosmetic powder' 36,37,38. Documented buyer losses in the same supply channel run $107, $400, $600, $800 and $13,000, frequently via crypto and fake shipping entities 81,82802625. Buyers themselves flag crypto/bank-transfer demands as the primary red flag and treat PayPal/Alipay/Alibaba as trust signals 2581,82. Chinese authorities have prosecuted 14 people for illegal production and sale of weight-loss drugs 74,75. If ignored: a single contaminated or mislabelled batch traced to an unverifiable supplier ends the brand — and the New England Compounding Center precedent is already the analogy clinicians are reaching for 7.
The numbers↑
Share of voice
Distinct items mentioning each entity. Counted per item, so one prolific poster cannot dominate.
Where the conversation lives
| Platform | Community | Items | Engagement | Comments read |
|---|---|---|---|---|
| Xiaohongshu | xiaohongshu.com | 84 | 18,861 | 0 |
| 27 | 0 | 0 | ||
| Zhihu | Zhihu | 19 | 39 | 0 |
| Peptides | 14 | 1,017 | 110 | |
| Business_China | 9 | 2,079 | 139 | |
| Web | www.perfectb.com | 7 | 0 | 0 |
| Biohacking | 5 | 1,281 | 58 | |
| Web | riteaid.com | 5 | 0 | 0 |
| Rumble | Rumble | 4 | 234 | 0 |
| Web | www.peptidedeck.com | 3 | 0 | 0 |
| Web | www.theguardian.com | 3 | 0 | 0 |
| Web | www.tiktok.com | 3 | 0 | 0 |
| PEDs | 2 | 124 | 33 | |
| Web | www.peptidedosingprotocols.com | 2 | 0 | 0 |
| Web | www.realpeptides.co | 2 | 0 | 0 |
Every figure in the corpus
Extracted mechanically from post and comment text. Repetition count is the signal: a number in one post is an anecdote, the same number in fifteen is a claim with a source worth tracing.
| Figure | Items citing it | Platforms | Context |
|---|---|---|---|
| 100% | 12 | Reddit, YouTube | Man I am thankful how lucky I got. I found a Chinese vendor and have had 100% satisfaction. Kinda scary how often I see these scammer post |
| 20% | 11 | Web, Reddit, Rumble, YouTube | t my face has dramatic collagen, firming, smoothness, and wrinkle reduction. But, since I’ve also lost around 20% of my body weight from 192 to 145lbs it’s hard to pin po |
| 50% | 9 | Web, YouTube | ndor That Shut Down (2025-2026) Verified vendors continuing to operate as of 2026 include Ascension Peptides (50% off auto), EZ Peptides, Ion Peptide (15% code), Glacier |
| 15% | 9 | Web, Reddit, YouTube | vendors continuing to operate as of 2026 include Ascension Peptides (50% off auto), EZ Peptides, Ion Peptide (15% code), Glacier Aminos, Dynamic Peptide, Swiss Chems, and |
| 99% | 8 | Reddit, Rumble, TikTok, Xiaohongshu, YouTube | umbs up to send it to the FDA for approval. Now, does it mean it's gonna be approved? Probably. I mean, like, 99% of the time, they're just gonna say yes, and it's good. |
| 10% | 7 | Web, Reddit, YouTube | our shirt like that, and you're good to go. Alternately, you can wear it on your wrist or in a lanyard. For a 10% discount, you can use the code carney at checkout. And i |
| 2mg | 6 | Reddit, YouTube | er stress. Curious why you bumped up to 6 mg reta so fast. Reta knocked me on my ass for a couple months at 1-2 mg. Now I'm at 4 mg after 6 months and the appetite suppre |
| 250mcg | 6 | Web, Reddit, TikTok, X | for the CJC/Ipa are you saying 250mcg of each totaling 500mcg injection? |
| 25% | 6 | Web, YouTube | 这话的时候脑子里就一个念头，完了，又送垮一个。 欧美那边第一批打司美格鲁肽的人，到现在差不多四年了，该来的全来了。脸部松弛、皮肉往下垮、精神萎靡、头晕恶心，这些东西不是小概率事件。今年就有期刊发文，用这类药减掉的体重里，25%到40%是肌肉。减重速度每周超过0.5公斤的人，皮肤松弛发生率高达68%。你拼命掉秤，掉的不是脂肪是肌肉，脸垮了、 |
| 5mg | 6 | Web, YouTube | h a lot of GHK-Cu. This is literally the last bit I have. >> Honestly with my GHK-Cu I'm only injecting 5 mg which is in fact a lot and it looks about like that muc |
| 10mg | 5 | Web, TikTok, YouTube | y-derived research planning. Direct human dose-finding trials are limited; a 2025 IV pilot in two adults used 10 mg and 20 mg single infusions and reported no adverse eff |
| 80% | 5 | Web, TikTok, YouTube, Zhihu | 减肥靠打针，靠谱吗？会反弹吗？ 减肥有用，能瘦很多 反弹包的，80%都会反弹 我5个月瘦了40斤，停针三个月，反弹了6斤 |
| 500mcg | 5 | Web, Reddit, TikTok | for the CJC/Ipa are you saying 250mcg of each totaling 500mcg injection? |
| 22% | 4 | Web, X, YouTube | &INTCMP=header_support_2025-07-23_JULY_DISCOUNT_HEADER__UK_EU_ROW_US_AUS_CONTROL&acquisitionData=%7B%22source%22%3A%22GUARDIAN_WEB%22%2C%22componentId%22%3A%22header_supp |
| 40% | 4 | YouTube | ear, if true, this would be very different than earlier drugs like Ozempic in this class where roughly 25% to 40% of weight loss comes from lean mass. But here's the thin |
| 30% | 4 | Web, X, YouTube | rketing system. Influencers frequently provide personalised discount codes, offering followers between 5% and 30% off purchases. |
| 90% | 4 | Web, TikTok, X, YouTube | roved for human consumption #peppers #biohacking I just want to let you guys know that I would argue probably 90% of peptide companies out there are selling peptides that |
| 60% | 4 | TikTok, Xiaohongshu, YouTube | growing, forming new connections and getting better with time, not declining. P 21 up regulates BDNF by 40 to 60%. That's not a small number, that is a big number. That i |
| 70% | 4 | TikTok, YouTube | n a kit of GHKCU, the 10 vials, one peptide that has like 99.8% purity and another peptide that literally has 70% purity. So you are literally rolling the roulette wheel |
| 1% | 4 | TikTok, YouTube | The copper peptide serum you bought probably has too much in it. Research backs 0.1% to 1%. Products claiming 2–3%? No data. Could actually backfire. As pharmacists, this |
Stance split
| Stance | Items | Share | Engagement |
|---|---|---|---|
| na | 119 | 31% | 495,968 |
| pro | 103 | 27% | 375,238 |
| anti | 103 | 27% | 55,940 |
| mixed | 57 | 15% | 147,077 |
What this report could not establish↑
Geography. The brief asked for US, UK and China. US evidence is deep (Reddit 36 items with 362 comments read, X 56, YouTube 59, TikTok 29). China evidence is broad but shallow in a specific way: Xiaohongshu contributes the largest single block (84 items) but 0 comments were read across all 84, and 0 comments were read on WeChat (27 items) and Zhihu (19 items) — so we can characterise what Chinese posters and sellers say, but not what Chinese consumers reply. Weibo is a single item. The UK is effectively absent as a consumer market: we have Guardian web items (3) and one Reddit commenter saying \"I buy off legit UK suppliers theres plenty\" 83, plus Xiaohongshu shipping-line advertising to the UK 36,37,38. There is no UK-specific evidence on MHRA posture, UK sourcing channels, UK prices or UK clinician commentary. Any UK go-to-market decision needs separate primary research.\n\nThe regulatory outcome is genuinely unresolved in this corpus. Sources contradict each other on whether the 23–24 July 2026 PCAC meeting rejected all seven peptides or recommended four of them 16,17,1819,20. Both readings are present in strong-strength findings. We could not locate the official FDA meeting minutes or Federal Register text, so the exact vote tallies (reported variously as 8-6-1 and as four straight YES votes, and 8-5 for Semax) should be treated as press-and-social reconstructions 7,8,951,52,53. We could not establish a date for final FDA action.\n\nNo prevalence or incidence data. Share of voice measures conversation, not purchase. We cannot say how many people are injecting, what the repeat-purchase rate is, or what average annual spend looks like. The $1–3bn market size is an investor estimate relayed by Bloomberg, not an audited figure 60,66. The claim that '90% of peptide companies' sell unverified product is one TikTok creator's estimate 27,28; the ~20% mislabelling rate is attributed to Topol summarising independent labs, without the underlying study cited 29.\n\nHarm is asserted, not quantified. The claim of rising ER visits from Reddit-sourced research chemicals rests on a single X post from a commercially interested account and should not be repeated as fact 81,82. We found one specific Chinese hospitalisation case (dehydration shock after illegally-sourced semaglutide) 97,98,99 and self-reported chest pain on Clenbuterol 76 and carpal-tunnel symptoms on HGH 50 — but no adverse-event registry data, no case series, and no denominator for any of it.\n\nPlatforms and channels not covered. Telegram and Discord are repeatedly named as where vetting and group-testing actually happen 848379, but no Telegram or Discord content was directly captured — we only have Reddit users describing them. Instagram and Facebook are named as scam-ad vectors 79 without direct evidence. Amazon, eBay and mainstream e-commerce listings were not examined. Alibaba, cited as a trust signal 25, was not sampled directly.\n\nPricing and unit economics are anecdotal. Figures in the corpus ($200/10-vial kit, $35/10 vials as a scam signal, $50–90 shipping, $250–600 testing) come from individual Reddit comments, not a price survey 767778. We have no landed-cost, margin or compounding-pharmacy price data, which is the number that decides whether the recommendation to price against the gray benchmark is achievable.\n\nEngagement data is uneven. Recorded engagement for semaglutide (0), tirzepatide (21) and 替尔泊肽 (82) is near-zero, while BPC-157 shows 526k — this reflects platform metric availability (WeChat and web sources return no engagement figures) rather than genuine indifference to GLP-1s. Do not read GLP-1 engagement as low.\n\nNot established: whether any legitimate brand has successfully converted gray-market buyers; whether third-party COA transparency actually shifts purchase behaviour or is merely stated as a preference; what proportion of self-injectors would pay a compounding-pharmacy premium; and any clinician view from the UK or China on the compounding question.
Methodology↑
Retrieval angles
Each angle is an independent pass over the last 30 days using different vocabulary. One query finds only what one query's words reach.
| Angle | Evidence type | Query | Status |
|---|---|---|---|
| peptide-stack-testimony | testimony | BPC-157 TB-500 ipamorelin CJC-1295 results before after log, week 4 update, 'started injecting', side effects, weight loss, healing, sleep quality, sub-q injection site bruising, r | ran |
| gray-market-sourcing | commerce | buy peptides research chemicals no PED website, 'for research purposes only' vial, reconstitute with bac water, best peptide vendor reddit, China lab reship, Alibaba peptide suppli | ran |
| clinician-alarm | expertise | doctor warns patients self-injecting peptides unregulated compounding pharmacy FDA untested contamination risk, endocrinologist Twitter thread peptide therapy dangers, GP comments | ran |
| overhyped-skeptic-backlash | dissent | peptides are a scam, waste of money, placebo, no proof it works, bro science TikTok peptide grift, 'snake oil' longevity influencer callout, retatrutide semaglutide alternative hyp | ran |
| uk-china-regulatory-region | region | 肽 自己注射 效果 副作用 减脂 修复 小红书 论坛, UK peptide import banned MHRA crackdown reddit UKGymBros, buying peptides legal grey area Britain forum post customs seizure | ran |
Source qualification
A source earns a place in this report by contributing evidence, not by having been queried. Sources below the precision floor are excluded from the findings and from every count above.
| Source | Retrieved | On-topic | Precision | Verdict | Reason |
|---|---|---|---|---|---|
| Xiaohongshu | 332 | 84 | 25% | kept | |
| Web | 66 | 61 | 92% | kept | |
| YouTube | 69 | 59 | 86% | kept | |
| X | 137 | 56 | 41% | kept | |
| 66 | 36 | 55% | kept | ||
| TikTok | 45 | 29 | 64% | kept | |
| 38 | 27 | 71% | kept | ||
| Zhihu | 293 | 19 | 6% | kept | |
| douyin | 143 | 10 | 7% | dropped | 10/143 items on-topic (7%) — below the 25% floor |
| Bluesky | 9 | 6 | 67% | kept | |
| Rumble | 8 | 4 | 50% | kept | |
| Hacker News | 32 | 2 | 6% | dropped | 2/32 items on-topic (6%) — below the 25% floor |
| 3 | 1 | 33% | kept | ||
| Digg | 141 | 0 | 0% | dropped | 0/141 items on-topic (0%) — below the 25% floor |
| 4chan | 90 | 0 | 0% | dropped | 0/90 items on-topic (0%) — below the 25% floor |
| Bilibili | 6 | 0 | 0% | dropped | 0/6 items on-topic (0%) — below the 25% floor |
| Kwai | 1 | 0 | 0% | dropped | 0/1 items on-topic (0%) — below the 25% floor |
| Telegram | 24 | 0 | 0% | dropped | 0/24 items on-topic (0%) — below the 25% floor |
| 3 | 0 | 0% | dropped | 0/3 items on-topic (0%) — below the 25% floor | |
| GitHub | 4 | 0 | 0% | dropped | 0/4 items on-topic (0%) — below the 25% floor |
| Threads | 7 | 0 | 0% | dropped | 0/7 items on-topic (0%) — below the 25% floor |
Evidence funnel
| Stage | Count |
|---|---|
| Unique items retrieved | 1,517 |
| Passed relevance screening | 382 |
| Re-fetched at full depth | 94 |
| Comments read in full | 362 |
| Words of evidence analysed | 202,068 |
| Findings extracted | 305 |
| Bot/boilerplate comments filtered | 23 |
Window: 2026-06-25 → 2026-07-25. Generated 2026-07-25T11:14:14+00:00.